IDEXX Laboratories, Inc. Share Price

Equities

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 24/05/2024 BST 5-day change 1st Jan Change
516.5 USD +0.08% Intraday chart for IDEXX Laboratories, Inc. -4.96% -6.95%
Sales 2024 * 3.94B 310B Sales 2025 * 4.34B 341B Capitalization 42.66B 3,349B
Net income 2024 * 922M 72.39B Net income 2025 * 1.04B 81.34B EV / Sales 2024 * 10.9 x
Net Debt 2024 * 396M 31.08B Net Debt 2025 * 223M 17.5B EV / Sales 2025 * 9.88 x
P/E ratio 2024 *
46.6 x
P/E ratio 2025 *
41.3 x
Employees 11,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.08%
1 week-4.96%
Current month+4.82%
1 month+4.50%
3 months-10.37%
6 months+8.01%
Current year-6.95%
More quotes
1 week
511.78
Extreme 511.7845
545.43
1 month
462.00
Extreme 462
548.88
Current year
462.00
Extreme 462
583.39
1 year
372.50
Extreme 372.5
583.39
3 years
317.06
Extreme 317.06
706.95
5 years
168.65
Extreme 168.65
706.95
10 years
56.75
Extreme 56.745
706.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 31/07/12
Director of Finance/CFO 61 30/06/03
Chief Operating Officer - 31/12/07
Members of the board TitleAgeSince
Director/Board Member 71 10/03/14
Director/Board Member 73 15/07/12
Chairman 61 18/10/16
More insiders
Date Price Change Volume
24/05/24 516.5 +0.08% 267,200
23/05/24 516.1 -0.36% 503,767
22/05/24 517.9 -0.10% 494,511
21/05/24 518.4 -2.19% 486,559
20/05/24 530.1 -2.46% 517,352

Delayed Quote Nasdaq, May 24, 2024 at 09:00 pm

More quotes
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
516.5 USD
Average target price
563.8 USD
Spread / Average Target
+9.16%
Consensus